Get started
Author

Paige Bayer

Observed name: P. Bayer
ORCID: 0000-0003-4884-5873
Observed ORCID: 0000-0003-4884-5873
OpenAlex ID: A5063995643
Identifying MAGE-A4-positive tumors for TCR T cell therapies in HLA-A∗02-eligible patients
2024 · Tianjiao Wang, Jean-Marc Navenot, et al. · Molecular Therapy — Methods & Clinical Development · 21
The SPEARHEAD-1 trial of afamitresgene autoleucel (afami-cel [formerly ADP-A2M4]): Analysis of overall survival in advanced synovial sarcoma.
2023 · Brian Andrew Van Tine, Kristen N. Ganjoo, et al. · Journal of Clinical Oncology · 8
Abstract LB001: Identifying MAGE-A4-positive tumors for SPEAR T-cell therapies in HLA-A*02-eligible patients
2022 · Tianjiao Wang, Jean-Marc Navenot, et al. · Cancer Research · 2
Performance status and quality of life in patients with advanced synovial sarcoma or myxoid/round cell liposarcoma receiving afamitresgene autoleucel
2025 · M.J. Wagner, C. Lunt, et al. · ESMO rare cancers.
Works count: 4
Citation count: 31
H-index: 2
I10-index: 1
Year
Topic
Type